Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

Novartis pulls ahead of Merck in MET-positive lung cancer race

Novartis pulls ahead of Merck in MET-positive lung cancer race

Capmatinib – originally developed by Incyte and licensed to Novartis in 2009 – has been submitted for approval in the US for metastatic MET exon14 skipping-mutated NSCLC, a form of lung cancer

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys to patients and the clinical community around the world,” said Hervé Hoppenot, CEO of Incyte. ... Under the terms of the deal, Incyte is paying MorphoSys $750m upfront, as well as making an equity investment worth $150m in the company.

Incyte claims FDA priority review for bile duct cancer drug

Incyte claims FDA priority review for bile duct cancer drug Significant need for new therapies in hard-to-treat cancer type. Incyte’s new drug pemigatinib has been given a priority review for a rare type of bile duct cancer by ... Incyte says cholangiocarcinoma affects between 0.3 – 3.4 people per 100, 000 in

CML LIFE

by INCYTE with support from Open Health PBC. CML Life has been developed using evidence-based methodology, including an extensive literature review focusing on engagement, adherence and side effect management. ... CML LIFE - by INCYTE with support from

Life Effects

CML LIFE - by INCYTE with support from Open Health PBC.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics